Latest News

LPL Financial Welcomes Praxis Financial Partners

Fortune Media and Great Place To Work® Name Kaplan No. 1 on 2026 Best Workplaces in Education & Training List

China Automotive Systems' Fully Redundant AP04 EPS Platform Meets ASPICE 4.0 CL2 in Joint Assessment by European OEM and UL

Presidio Property Trust Announces Expiration and Results of Exchange Offer for All Outstanding Shares of its Series D Preferred Stock

The Event Industry Power 50 Draws Record Voting, Passing 3,500 Ballots With Days Left

Kaplan Fox Reminds FuelCell Energy, Inc. (FCEL) Investors to Seek a Leadership Role Before Deadline on November 10, 2026 Ready to Announce with Confidence?

Indiana American Water Returns Nearly $75 in PFAS Settlement Credits to Customers

OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

Kaplan Fox Alerts Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) – Deadline is November 3, 2026